| scholarly article | Q13442814 |
| P2093 | author name string | Bouloy M | |
| Kohl A | |||
| Billecocq A | |||
| Vialat P | |||
| P2860 | cites work | The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis | Q24532096 |
| The carboxy-terminal acidic domain of Rift Valley Fever virus NSs protein is essential for the formation of filamentous structures but not for the nuclear localization of the protein. | Q27469709 | ||
| Genetic reassortment of Rift Valley fever virus in nature | Q27469727 | ||
| Polygenic control of neuroinvasiveness in California serogroup bunyaviruses | Q27486053 | ||
| A new generation of animal cell expression vectors based on the Semliki Forest virus replicon | Q30014839 | ||
| Altered growth characteristics of recombinant respiratory syncytial viruses which do not produce NS2 protein | Q33639543 | ||
| Nonstructural C protein is required for efficient measles virus replication in human peripheral blood cells | Q33642486 | ||
| Reovirus growth in cell culture does not require the full complement of viral proteins: identification of a sigma1s-null mutant. | Q33785214 | ||
| Neuroattenuation of an avirulent bunyavirus variant maps to the L RNA segment. | Q36798269 | ||
| Neuroattenuated bunyavirus variant: derivation, characterization, and revertant clones | Q36804975 | ||
| Sindbis virus RNA polymerase is degraded by the N-end rule pathway | Q37604158 | ||
| Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter | Q39548682 | ||
| Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1. | Q39578343 | ||
| The Rift Valley fever virus nonstructural protein NSs is phosphorylated at serine residues located in casein kinase II consensus motifs in the carboxy-terminus | Q40630761 | ||
| Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation | Q40642621 | ||
| Persistent infection of mammalian cells by Rift Valley fever virus | Q40660523 | ||
| Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. | Q40679919 | ||
| Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine | Q40759549 | ||
| Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development | Q40814834 | ||
| Protein synthesis in Rift Valley fever virus-infected cells | Q40827849 | ||
| The paramyxovirus SV5 small hydrophobic (SH) protein is not essential for virus growth in tissue culture cells | Q41003033 | ||
| Non-random reassortment between the tripartite RNA genomes of La Crosse and snowshoe hare viruses | Q41096788 | ||
| Normal replication of vesicular stomatitis virus without C proteins | Q42628502 | ||
| Evaluation of the susceptibility of the 3C proteases of hepatitis A virus and poliovirus to degradation by the ubiquitin-mediated proteolytic system | Q45760522 | ||
| Genetic reassortment among viruses causing hantavirus pulmonary syndrome | Q46102334 | ||
| An outbreak of Rift Valley Fever, eastern Africa, 1997-1998 | Q74522206 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Rift Valley fever | Q326638 |
| Bunyaviridae | Q1010102 | ||
| Rift Valley fever phlebovirus | Q24809101 | ||
| P1104 | number of pages | 6 | |
| P304 | page(s) | 1538-1543 | |
| P577 | publication date | 2000-02-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice | |
| P478 | volume | 74 |
| Q33316823 | A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. |
| Q39640664 | A silencing suppressor protein (NSs) of a tospovirus enhances baculovirus replication in permissive and semipermissive insect cell lines. |
| Q35616459 | A ΩXaV motif in the Rift Valley fever virus NSs protein is essential for degrading p62, forming nuclear filaments and virulence |
| Q34334411 | Andes virus M genome segment is not sufficient to confer the virulence associated with Andes virus in Syrian hamsters. |
| Q34895197 | Antigenic drift, antigenic shift and interferon antagonists: how bunyaviruses counteract the immune system |
| Q54217244 | Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates. |
| Q39776458 | Bunyamwera virus nonstructural protein NSs counteracts interferon regulatory factor 3-mediated induction of early cell death |
| Q56537260 | Bunyavirus: Hemorrhagic Fevers |
| Q30671497 | Characterization of the Sandfly fever Naples species complex and description of a new Karimabad species complex (genus Phlebovirus, family Bunyaviridae). |
| Q33405078 | Characterization of the Uukuniemi virus group (Phlebovirus: Bunyaviridae): evidence for seven distinct species |
| Q40199478 | Comparative efficacy of two next-generation Rift Valley fever vaccines |
| Q33959989 | Comparative pathogenesis and systems biology for biodefense virus vaccine development |
| Q38748778 | Creation of a recombinant Rift Valley fever virus with a two-segmented genome |
| Q37321966 | Development of a RVFV ELISA that can distinguish infected from vaccinated animals |
| Q35126733 | Development of a novel, single-cycle replicable rift valley Fever vaccine |
| Q36559849 | Dicer-2- and Piwi-mediated RNA interference in Rift Valley fever virus-infected mosquito cells |
| Q40101969 | Discovery and characterisation of a new insect-specific bunyavirus from Culex mosquitoes captured in northern Australia |
| Q39893246 | Efficient production of Rift Valley fever virus-like particles: The antiviral protein MxA can inhibit primary transcription of bunyaviruses |
| Q40358602 | Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep |
| Q33406066 | Evolutionary and molecular analysis of the emergent severe fever with thrombocytopenia syndrome virus |
| Q40059072 | Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy |
| Q39601913 | Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs |
| Q33918307 | Host alternation is necessary to maintain the genome stability of rift valley fever virus |
| Q35801885 | Induction of DNA damage signaling upon Rift Valley fever virus infection results in cell cycle arrest and increased viral replication |
| Q38376184 | Interplay between the Virus and Host in Rift Valley Fever Pathogenesis |
| Q96304864 | Livestock Challenge Models of Rift Valley Fever for Agricultural Vaccine Testing |
| Q33442499 | Mapping of transcription termination within the S segment of SFTS phlebovirus facilitated the generation of NSs-deletant viruses |
| Q30562554 | Metagenomic shotgun sequencing of a Bunyavirus in wild-caught Aedes aegypti from Thailand informs the evolutionary and genomic history of the Phleboviruses |
| Q57017486 | Molecular Biology of Rift Valley Fever Virus~!2009-11-04~!2009-11-25~!2010-04-22~! |
| Q36652695 | Molecular biology and genetic diversity of Rift Valley fever virus |
| Q33886954 | Molecular biology of rift valley Fever virus |
| Q35849036 | Molecular epidemiology of Rift Valley fever virus |
| Q39960501 | NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription |
| Q42218809 | NSs protein of Schmallenberg virus counteracts the antiviral response of the cell by inhibiting its transcriptional machinery |
| Q39195523 | NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase |
| Q39547955 | NSs protein of rift valley fever virus promotes posttranslational downregulation of the TFIIH subunit p62. |
| Q34465842 | Negative-strand tospoviruses and tenuiviruses carry a gene for a suppressor of gene silencing at analogous genomic positions |
| Q39778891 | Nonstructural NSs protein of rift valley fever virus interacts with pericentromeric DNA sequences of the host cell, inducing chromosome cohesion and segregation defects. |
| Q33604965 | Pathogenicity of Hantaan virus in newborn mice: genetic reassortant study demonstrating that a single amino acid change in glycoprotein G1 is related to virulence |
| Q26747457 | Phleboviruses and the Type I Interferon Response |
| Q27487321 | RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses |
| Q27491320 | Rapid Accumulation of Virulent Rift Valley Fever Virus in Mice from an Attenuated Virus Carrying a Single Nucleotide Substitution in the M RNA |
| Q45324172 | Recent advances in the development of antiviral therapeutics for Rift Valley fever virus infection. |
| Q38614407 | Restriction of rift valley Fever virus virulence in mosquito cells |
| Q27469774 | Reverse genetics system for Uukuniemi virus (Bunyaviridae): RNA polymerase I-catalyzed expression of chimeric viral RNAs |
| Q33570326 | Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines |
| Q34475358 | Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments. |
| Q40038707 | Rift Valley fever phlebovirus NSs protein core domain structure suggests molecular basis for nuclear filaments |
| Q36827204 | Rift Valley fever virus clearance and protection from neurologic disease are dependent on CD4+ T cell and virus-specific antibody responses |
| Q40308414 | Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection. |
| Q40453546 | Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease. |
| Q40237478 | Rift Valley fever virus structural and nonstructural proteins: recombinant protein expression and immunoreactivity against antisera from sheep. |
| Q34221766 | Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep |
| Q33960690 | Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention |
| Q26795706 | Rift Valley fever virus: A review of diagnosis and vaccination, and implications for emergence in Europe |
| Q37393780 | Rift valley fever vaccines |
| Q36484009 | Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals |
| Q40144467 | Safety and immunogenicity of Onderstepoort Biological Products' Rift Valley fever Clone 13 vaccine in sheep and goats under field conditions in Senegal. |
| Q34550761 | Schmallenberg virus pathogenesis, tropism and interaction with the innate immune system of the host. |
| Q35868079 | Single-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge |
| Q33198557 | TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. |
| Q33602836 | The NSs protein of tomato spotted wilt virus is required for persistent infection and transmission by Frankliniella occidentalis |
| Q64252092 | The One Health Approach is Necessary for the Control of Rift Valley Fever Infections in Egypt: A Comprehensive Review |
| Q27478045 | The S Segment of Punta Toro Virus (Bunyaviridae, Phlebovirus) Is a Major Determinant of Lethality in the Syrian Hamster and Codes for a Type I Interferon Antagonist |
| Q36155392 | The dominant-negative inhibition of double-stranded RNA-dependent protein kinase PKR increases the efficacy of Rift Valley fever virus MP-12 vaccine |
| Q40174551 | The genetic basis for susceptibility to Rift Valley fever disease in MBT/Pas mice |
| Q40306367 | The nonstructural protein NSs induces a variable antibody response in domestic ruminants naturally infected with Rift Valley fever virus |
| Q34191969 | The pathogenesis of Rift Valley fever |
| Q39066685 | Vaccination of alpacas against Rift Valley fever virus: Safety, immunogenicity and pathogenicity of MP-12 vaccine. |
| Q33617793 | Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus |
| Q24319790 | p53 Activation following Rift Valley fever virus infection contributes to cell death and viral production |
Search more.